欧洲药典适用性证书数据库
(Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM)
专论编号 物质名称 证书持有人 持有人ORG-ID和LOC-ID 证书编号 发布日期 证书状态 到期续期 证书结束日期 证书类型 上一程序的结束日期 历史数据
程序类型|结论|日期
1444 Macrogols, Type 4000 NANJING WELL PHARMACEUTICAL GROUP CO., LTD. Nanjing CN 100051565;100090508 CEP 2025-274 - Rev 00 2026/02/06 Valid 06/02/2031 Chemical 2026/02/06 New application|CEP granted|06/02/2026
2771 Ibandronate sodium monohydrate MAPRIMED S.A. Buenos Aires AR 100012039;100018552 CEP 2025-243 - Rev 00 2026/02/06 Valid 06/02/2031 Chemical 2026/02/06 New application|CEP granted|06/02/2026
. Purified bovine Haemoglobin, Compound 800 (C-800) BIOS BIOTECHNOLOGY COMPANY LTD. Hong Kong Island HK 100054542;100096660 CEP 2020-428 - Rev 01 2026/02/05 Valid 26/10/2026 TSE 2026/02/05 Transfer of holdership|CEP granted|05/02/2026;
Major revision|Accepted - CEP remains valid|07/08/2025;
New application|CEP granted|26/10/2021
1246 Nitrendipine EGIS Pharmaceuticals PLC Budapest X HU 100001091;100001662 CEP 2019-209 - Rev 02 2026/02/05 Valid Chemical 2026/02/05 Monograph revision|CEP granted|05/02/2026;
Renewal|CEP granted|18/06/2025;
Notification|Accepted - CEP remains valid|29/07/2022;
Minor revision|Accepted - CEP remains valid|20/11/2020
758 Colchicine CHEMICAL RESOURCES Panchkula IN 100048957;100082031 CEP 2023-446 - Rev 00 2026/02/05 Valid 05/02/2031 Chemical 2026/02/06 New application|CEP granted|06/02/2026
2600 Olmesartan medoxomil, Micronised YANTAI VALIANT PHARMACEUTICAL CO. LTD. Yantai CN 100044353;100073319 CEP 2024-350 - Rev 01 2026/02/05 Valid 26/01/2031 Chemical 2026/02/05 Administrative procedure|CEP granted|05/02/2026;
New application|CEP granted|26/01/2026
1569 Sufentanil SPECGX LLC Webster Groves US 100017269;100031662 CEP 2019-054 - Rev 01 2026/02/05 Valid Chemical 2026/02/05 Renewal|CEP granted|05/02/2026;
Minor revision|Accepted - CEP remains valid|08/04/2024
2866 Gefitinib SAKAR HEALTHCARE LIMITED Ahmedabad IN 100033943;100085048 CEP 2024-578 - Rev 00 2026/02/05 Valid 05/02/2031 Chemical 2026/02/05 New application|CEP granted|05/02/2026
2857 Trazodone hydrochloride MAHI DRUGS PRIVATE LIMITED Hyderabad IN 100048039;100079525 CEP 2024-399 - Rev 00 2026/02/05 Valid 05/02/2031 Chemical 2026/02/05 New application|CEP granted|05/02/2026
1654 Lymecycline VIRDEV INTERMEDIATES PVT. LTD. Surat IN 100049143;100082993 CEP 2024-386 - Rev 00 2026/02/05 Valid 05/02/2031 Chemical 2026/02/05 New application|CEP granted|05/02/2026
2631 Rosuvastatin calcium, Process III NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo CN 100030313;100047776 CEP 2025-486 - Rev 00 2026/02/05 Valid 05/02/2031 Chemical 2026/02/05 New application|CEP granted|05/02/2026
1491 Amlodipine besilate, Process II NOVARTIS PHARMA AG Basel CH 100003908;100000364 CEP 2008-122 - Rev 03 2026/02/04 Valid Chemical 2026/02/04 Monograph revision|CEP granted|04/02/2026;
Notification|CEP granted|14/12/2023;
Minor revision|Accepted - CEP remains valid|29/08/2022
388 Dexamethasone, Crystalline Form-B XI’AN GUOKANG RUIJIN PHARMACEUTICAL CO., LTD. Xi’an CN 100039231;100096104 CEP 2023-244 - Rev 00 2026/02/04 Valid 04/02/2031 Chemical 2026/02/04 New application|CEP granted|04/02/2026
2577 Oxcarbazepine, Micronised and non-micronised HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou CN 100015482;100024200 CEP 2018-165 - Rev 05 2026/02/04 Valid Chemical 2026/02/04 Minor revision|CEP granted|04/02/2026;
Administrative procedure|CEP granted|02/12/2024;
Minor revision|CEP granted|21/11/2024;
Renewal|CEP granted|03/10/2024;
Minor revision|CEP granted|07/07/2023
942 Omeprazole, Micronised and sieved grade ESTEVE QUIMICA S.A. Barcelona ES 100002266;100056508 CEP 1998-145 - Rev 12 2026/02/04 Valid Chemical 2026/02/04 Notification|CEP granted|04/02/2026;
Minor revision|CEP granted|12/07/2024;
Notification|Accepted - CEP remains valid|20/04/2023;
Transfer of holdership|CEP granted|16/03/2022;
Notification|Accepted - CEP remains valid|04/11/2021;
Notification|CEP granted|24/03/2020
2932 Rivaroxaban HETERO DRUGS LIMITED Hyderabad IN 100008415;100014434 CEP 2023-231 - Rev 02 2026/02/04 Valid 19/11/2029 Chemical 2026/02/04 Administrative procedure|CEP granted|04/02/2026;
Minor revision|CEP granted|26/01/2026;
Notification|Rejected|17/12/2025;
Minor revision|Accepted - CEP remains valid|10/07/2025;
New application|CEP granted|19/11/2024
859 Pyrazinamide ANUH PHARMA LIMITED Mumbai IN 100021566;100030259 CEP 2005-059 - Rev 04 2026/02/04 Valid Chemical 2026/02/04 Notification|CEP granted|04/02/2026;
Minor revision|CEP granted|30/04/2020
401 Levothyroxine sodium hydrate MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN 100011732;100023530 CEP 2025-250 - Rev 00 2026/02/04 Valid 04/02/2031 Chemical 2026/02/04 New application|CEP granted|04/02/2026
2756 Amorolfine hydrochloride ZHEJIANG CDMO PHARMACEUTICAL CO., LTD Jinhua CN 100051857;100091157 CEP 2024-449 - Rev 00 2026/02/04 Valid 04/02/2031 Chemical 2026/02/04 New application|CEP granted|04/02/2026
2931 Sorafenib tosilate KINHOO PHARMACEUTICAL CO., LTD. Zhuhai CN 100050160;100087573 CEP 2024-398 - Rev 00 2026/02/04 Valid 04/02/2031 Chemical 2026/02/04 New application|CEP granted|04/02/2026

数据库说明:

当前数据更新日期:2026年05月28日。
©2006-2026 DrugFuture->Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM